A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Completed · Phase 2

Conditions studied: HIV Infections

In brief

The purpose of this study is to evaluate the safety, efficacy, and side effects of beta-D-2,6-diaminopurine dioxolane (DAPD) compared to DAPD plus mycophenolate mofetil (MMF) when these drugs are added to the anti-HIV treatment regimens of people infected with HIV. Some studies have shown that DAPD and MMF can help fight HIV. However, neither DAPD nor MMF has been approved by the Food and Drug Administration for treating HIV infection. This study will help doctors decide if DAPD and MMF are good drugs for treating HIV.

Key facts

Study ID
NCT00038272
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
56
Expected to finish
2006-04-01
Last updated by the study team
2021-11-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.